Bacteriocins and their position in the next wave of conventional antibiotics

International Journal of Antimicrobial Agents
Veronica L CaveraMichael L Chikindas

Abstract

Micro-organisms are capable of producing a range of defence mechanisms, including antibiotics, bacteriocins, lytic agents, protein exotoxins, etc. Such mechanisms have been identified in nearly 99% of studied bacteria. The multiplicity and diversity of bacteriocins and the resultant effects of their interactions with targeted bacteria on microbial ecology has been thoroughly studied and remains an area of investigation attracting many researchers. However, the incorporation of bacteriocins into drug delivery systems used in conjunction with, or as potential alternatives to, conventional antibiotics is only a recent, although rapidly expanding, field. The extensive array of bacteriocins positions them as one of the most promising options in the next wave of antibiotics. The goal of this review was to explore bacteriocins as novel antimicrobials, alone and in combination with established antibiotics, and thus position them as a potential tool for addressing the current antibiotic crisis.

References

Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·K Schaller, M Nomura
Oct 31, 2002·Applied and Environmental Microbiology·Daili Jacqueline Aguilar NetzHans-Georg Sahl
Nov 29, 2002·Current Drug Targets. Infectious Disorders·W S Champney
Nov 19, 2003·Journal of Molecular Biology·M J Sánchez-BarrenaA Albert
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Anne-Marie PonsGilles Cottenceau
Mar 12, 2004·The EMBO Journal·Marc GrailleMiklos de Zamaroczy
Mar 22, 2005·Current Pharmaceutical Design·Osnat GillorMargaret A Riley
Nov 3, 2005·Journal of the American Chemical Society·Champak ChatterjeeWilfred A van der Donk
Apr 6, 2006·Current Microbiology·Mariana Buss Cezar FontanaAdriano Brandelli
Jun 6, 2006·Applied and Environmental Microbiology·Paul D CotterR Paul Ross
Sep 12, 2006·Nucleic Acids Research·Tetsuhiro OgawaHaruhiko Masaki
Oct 21, 2006·Chemistry & Biology·Champak ChatterjeeWilfred A van der Donk
Dec 1, 2006·Analytical Biochemistry·Ross T FernleyIan Macreadie
Feb 8, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dzung B DiepIngolf F Nes
Aug 28, 2007·Research in Microbiology·Marcus Lívio Varella CoelhoMaria do Carmo de Freire Bastos
Oct 13, 2007·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·Jun F Allard, Andrew D Rutenberg
Jan 20, 2009·Current Pharmaceutical Biotechnology·M C F BastosJ S Nascimento
May 26, 2009·Biochimica Et Biophysica Acta·Xiandi GongMarek Duszyk
May 28, 2009·Antimicrobial Agents and Chemotherapy·Fuminori YoneyamaKenji Sonomoto
Dec 2, 2009·Applied and Environmental Microbiology·Mariano Prado-AcostaCarmen Sanchez Rivas
Jul 29, 2010·The ISME Journal·Hadeel MajeedMargaret A Riley
Oct 12, 2010·Applied and Environmental Microbiology·Pearl M SweRalph W Jack
Nov 26, 2010·Applied and Environmental Microbiology·Annechien PlatGert N Moll
Feb 2, 2011·Antimicrobial Agents and Chemotherapy·Fuminori YoneyamaKenji Sonomoto
Apr 27, 2011·ACS Chemical Biology·Ian M GutWilfred A van der Donk
Sep 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sven van TeeffelenZemer Gitai
Nov 4, 2011·Nature Reviews. Microbiology·Karen BushHelen I Zgurskaya
Jan 20, 2012·International Journal of Food Microbiology·François BourdichonEgon Bech Hansen
Feb 15, 2012·Journal of the American Chemical Society·Mohammad R IslamKenji Sonomoto
Aug 17, 2012·Current Pharmaceutical Design·Gabriel O GutkindMarcela Radice
Dec 12, 2012·International Journal of Molecular Sciences·Yanhua CuiHongyu Cui
Feb 5, 2013·BMC Microbiology·Alicia CampionR Paul Ross
Apr 18, 2013·PloS One·Frédéric CollinAnthony Maxwell
Apr 26, 2013·Biology Letters·R Fredrik InglisMartin Ackermann
May 1, 2013·Nature Reviews. Drug Discovery·Kim Lewis

❮ Previous
Next ❯

Citations

May 7, 2016·Current Oral Health Reports·Benjamin CrossRobert G Quivey
Dec 8, 2015·Frontiers in Microbiology·Des FieldR P Ross
May 4, 2016·Proceedings of the National Academy of Sciences of the United States of America·Juan J QueredaJavier Pizarro-Cerda
Oct 19, 2016·Current Opinion in Microbiology·Michael Wittekind, Raymond Schuch
Jun 9, 2016·Current Opinion in Structural Biology·Milton H Saier
Jul 28, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·In Young HwangMatthew Wook Chang
Sep 18, 2016·Archives of Microbiology·Shelly L PringleRobert J C McLean
Oct 23, 2016·Cellular and Molecular Life Sciences : CMLS·T P Tim CushnieAndrew J Lamb
Nov 12, 2016·Frontiers in Microbiology·Des FieldColin Hill
Jan 28, 2017·Journal of Theoretical Biology·Sharon BewickWilliam F Fagan
Jun 28, 2016·Applied and Environmental Microbiology·Marija MiljkovicMilan Kojic
Feb 9, 2017·Antimicrobial Agents and Chemotherapy·María Ángeles AbengózarLuis Rivas
Mar 21, 2019·The Journal of Infectious Diseases·Vincent Cattoir, Brice Felden
Aug 26, 2016·Probiotics and Antimicrobial Proteins·Ahmed K Al AtyaDjamel Drider
Nov 26, 2019·Annals of the New York Academy of Sciences·Craig R MacNairEric D Brown
Mar 4, 2020·Journal of Medical Microbiology·Abdu AldarhamiMathew Upton
Jun 7, 2017·BMC Infectious Diseases·Mitra GholamiShahram Nazari
Nov 1, 2018·Bioengineering & Translational Medicine·Kathryn G GeldartYiannis N Kaznessis
Aug 27, 2019·Frontiers in Microbiology·Simona Iacob, Diana Gabriela Iacob
Apr 28, 2018·Animal Frontiers : the Review Magazine of Animal Agriculture·Benjamin P WillingBenjamin C T Bourrie
Dec 14, 2018·The Biochemical Journal·William A CramerS D Zakharov
Apr 13, 2017·Veterinary Research·Amel Ben LaghaDaniel Grenier
Jun 28, 2018·Frontiers in Microbiology·Jesús Perales-AdánMercedes Maqueda
Jan 19, 2020·Fish Physiology and Biochemistry·Felix K A KuebutornyeCai Xia Xie
Oct 6, 2020·Frontiers in Immunology·Nannette Y YountMichael R Yeaman
Jul 14, 2020·Veterinary Research Communications·Laureano SchofsSergio F Sánchez Bruni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Vaginosis

Bacterial vaginosis can increase the risk of sexually transmitted infections and in rare cases lead to pelvic inflammatory diseases. Discover the latest research on Bacterial Vaginosis here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Annual Review of Microbiology
M A Riley, John E Wertz
Journal of Infection in Developing Countries
Zhabiz GolkarDonald Gene Pace
© 2021 Meta ULC. All rights reserved